NO844501L - Oksazolidiner. - Google Patents
Oksazolidiner.Info
- Publication number
- NO844501L NO844501L NO844501A NO844501A NO844501L NO 844501 L NO844501 L NO 844501L NO 844501 A NO844501 A NO 844501A NO 844501 A NO844501 A NO 844501A NO 844501 L NO844501 L NO 844501L
- Authority
- NO
- Norway
- Prior art keywords
- phenyl
- formula
- optionally
- residue
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH6070/83A CH655931A5 (en) | 1983-11-10 | 1983-11-10 | Oxazolidines |
| CH449984 | 1984-09-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO844501L true NO844501L (no) | 1985-05-13 |
Family
ID=25695620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO844501A NO844501L (no) | 1983-11-10 | 1984-11-09 | Oksazolidiner. |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US4743604A (da) |
| AT (1) | AT387771B (da) |
| AU (1) | AU576531B2 (da) |
| BE (1) | BE900983A (da) |
| CA (1) | CA1249992A (da) |
| DE (1) | DE3438411A1 (da) |
| DK (1) | DK520584A (da) |
| ES (1) | ES8606863A1 (da) |
| FI (1) | FI844152A7 (da) |
| FR (1) | FR2554814B1 (da) |
| GB (1) | GB2149405B (da) |
| HU (1) | HU193465B (da) |
| IL (1) | IL73427A (da) |
| IT (1) | IT1177033B (da) |
| LU (1) | LU85631A1 (da) |
| MC (1) | MC1641A1 (da) |
| NL (1) | NL8403308A (da) |
| NO (1) | NO844501L (da) |
| NZ (1) | NZ210105A (da) |
| PH (1) | PH22462A (da) |
| PT (1) | PT79485B (da) |
| SE (1) | SE463099B (da) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4968707A (en) * | 1987-06-10 | 1990-11-06 | Pfizer Inc. | Oxazolidin-2-one derivatives as hypoglycemic agents |
| FI892341L (fi) * | 1988-06-10 | 1989-12-11 | Hoffmann La Roche | Propanolaminderivat. |
| US5321036A (en) * | 1993-02-10 | 1994-06-14 | Bristol-Myers Squibb Company | Thiazole and oxazole-based β3 adrenergic receptor agonists |
| US5563171A (en) * | 1993-11-05 | 1996-10-08 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3-adrenergic agonists |
| US5578638A (en) * | 1993-11-05 | 1996-11-26 | American Cyanamid Company | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists |
| SK111195A3 (en) * | 1994-09-13 | 1997-06-04 | Sandoz Technology Ltd | Bicyclic ethers substituted with oxazole and thiazole, process for producing thereof and pharmaceutical composition containing same |
| US7510849B2 (en) * | 2004-01-29 | 2009-03-31 | Glucolight Corporation | OCT based method for diagnosis and therapy |
| US7254429B2 (en) | 2004-08-11 | 2007-08-07 | Glucolight Corporation | Method and apparatus for monitoring glucose levels in a biological tissue |
| US8036727B2 (en) * | 2004-08-11 | 2011-10-11 | Glt Acquisition Corp. | Methods for noninvasively measuring analyte levels in a subject |
| CA2604653A1 (en) | 2005-04-13 | 2006-10-19 | Glucolight Corporation | Method for data reduction and calibration of an oct-based blood glucose monitor |
| US8768423B2 (en) | 2008-03-04 | 2014-07-01 | Glt Acquisition Corp. | Multispot monitoring for use in optical coherence tomography |
| US9784726B2 (en) | 2013-01-08 | 2017-10-10 | Atrogi Ab | Screening method, a kit, a method of treatment and a compound for use in a method of treatment |
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202205895D0 (en) | 2022-04-22 | 2022-06-08 | Atrogi Ab | New medical uses |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA979912A (en) * | 1970-06-22 | 1975-12-16 | Frederic P. Hauck | Tetrahydronaphthyloxyaminopropanols and related compounds |
| GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
-
1984
- 1984-10-11 CA CA000465149A patent/CA1249992A/en not_active Expired
- 1984-10-19 DE DE19843438411 patent/DE3438411A1/de not_active Withdrawn
- 1984-10-22 FI FI844152A patent/FI844152A7/fi not_active Application Discontinuation
- 1984-10-25 IT IT23307/84A patent/IT1177033B/it active
- 1984-10-31 NL NL8403308A patent/NL8403308A/nl not_active Application Discontinuation
- 1984-11-01 US US06/667,186 patent/US4743604A/en not_active Expired - Fee Related
- 1984-11-01 DK DK520584A patent/DK520584A/da not_active Application Discontinuation
- 1984-11-05 NZ NZ210105A patent/NZ210105A/xx unknown
- 1984-11-05 IL IL73427A patent/IL73427A/xx unknown
- 1984-11-06 MC MC841735A patent/MC1641A1/fr unknown
- 1984-11-06 BE BE0/213953A patent/BE900983A/fr not_active IP Right Cessation
- 1984-11-07 LU LU85631A patent/LU85631A1/de unknown
- 1984-11-08 ES ES537487A patent/ES8606863A1/es not_active Expired
- 1984-11-08 FR FR8417009A patent/FR2554814B1/fr not_active Expired
- 1984-11-09 AT AT0355384A patent/AT387771B/de not_active IP Right Cessation
- 1984-11-09 GB GB08428335A patent/GB2149405B/en not_active Expired
- 1984-11-09 SE SE8405632A patent/SE463099B/sv not_active IP Right Cessation
- 1984-11-09 NO NO844501A patent/NO844501L/no unknown
- 1984-11-09 PT PT79485A patent/PT79485B/pt unknown
- 1984-11-09 AU AU35275/84A patent/AU576531B2/en not_active Ceased
- 1984-11-09 HU HU844174A patent/HU193465B/hu unknown
- 1984-11-09 PH PH31427A patent/PH22462A/en unknown
-
1988
- 1988-02-05 US US07/152,522 patent/US4871755A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO844501L (no) | Oksazolidiner. | |
| FI80030B (fi) | Nya fenyletanolaminer. | |
| NO159791B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fenoksypropanolaminer. | |
| JPH05148196A (ja) | ４−［２−（２−ヒドロキシ−２−フエニル−エチルアミノ）エトキシフエニル酢酸およびその生前駆体、その製造方法、およびそれを含有する調剤学的組成物 | |
| EP0254856A2 (de) | Pyridinäthanolaminderivate | |
| CS266593B2 (en) | Method of 2-(2-hydroxy-3-phenosypropylamine) ethoxyphenolh's derivativesprodduction | |
| EP0040915B1 (en) | Arylethanolamine derivatives, their preparation and use in pharmaceutical compositions | |
| EP0051917B1 (en) | Benzofuran ethanolamine derivatives, processes for their preparation, and their use in medicine | |
| EP0290122B1 (en) | Morpholine derivatives and their use | |
| US4500541A (en) | Pharmacologically active cyclopropane derivatives | |
| EP0094595B1 (de) | Neue Aziridin- und Phenäthanolaminderivate | |
| EP0198412B1 (de) | Phenäthanolaminderivate | |
| US5166218A (en) | Phenoxypropanolamines and pharmaceutical compositions thereof | |
| EP0142102B1 (en) | Tertiary amines | |
| AU622907B2 (en) | Propanolamine derivatives | |
| EP0139921B1 (en) | 2-phenylethylamine derivatives | |
| AU617353B2 (en) | Pyridylethanolamines | |
| WO1984004091A1 (en) | Pharmaceutically active 2-phenylethylamine derivatives | |
| JPS60115568A (ja) | オキサゾリジン類 | |
| WO1996031480A1 (en) | Novel heterocyclic compounds |